Unitree Shares Extend Slide, Now Half Below IPO Peak

Unitree Robotics shares fell as much as 4.3 percent to 546.51 yuan on Wednesday, September 2, extending a slide that has now erased more than half the stock's value since its Shanghai debut two weeks earlier and turning the most closely watched initial public offering in the humanoid robot industry into a live test of how much of China's robot boom was priced correctly the first time. The stock closed Wednesday's session more than 50 percent below the intraday high of 1,100 yuan it touched on its August 19 debut day, when shares briefly surged as much as 629 percent above the IPO price and gave the company a peak valuation near US$66 billion.

The numbers on both ends of that swing are real, which is what makes the story worth more than a single bad trading day. Unitree priced its Shanghai STAR Market offering at 150.80 yuan a share, raising roughly US$905 million and giving underwriter Citic Securities a valuation range the market blew through within hours of trading opening. Two weeks and a roughly 50 percent retracement later, the company's market value still sits at more than four times the top of that underwriter's original range, according to analysis reported by outlets tracking the listing. That is the sentence procurement teams and investors both need to sit with: even after one of the sharpest post-listing reversals a Shanghai newcomer has recorded, Unitree is not cheap by any measure the underwriters themselves used to price it.

The Trade That Made This a Story Twice

Wednesday's decline is not a new event in isolation; it is the latest data point in a slide that analysts first flagged as a bubble warning around August 25, when the stock had already fallen roughly 45 percent from its peak. What makes the September 2 session worth a separate look is that the decline continued past the point where a normal post-IPO cooldown should have stabilized, into new post-listing lows, on a day with no fresh company-specific bad news to explain it. Unitree opened book-building for the offering seeking a roughly US$6.2 billion valuation, a figure the market treated as a floor rather than a ceiling on debut day and has spent every session since renegotiating downward.

The company's own numbers give the sell-off a foothold beyond pure sentiment. Unitree's prospectus disclosed that adjusted net profit fell 53 percent to 40 million yuan, or roughly US$5.95 million, in the first quarter of 2026, a profitability trajectory that sits awkwardly next to a market capitalization that peaked near US$66 billion. A company can be the clear technology leader in quadruped and humanoid robotics, which Unitree by most industry measures is, and still carry a valuation that has separated from its near-term earnings power. Both things are true here, and the stock's two-week round trip is the market working out which one dominates the price.

What China's Listing Mechanism Rewarded

Part of the story is Unitree, and part of it is the mechanism that put the stock in front of buyers in the first place. Shanghai's STAR Market, designed to fast-track listings for technology companies the government has designated as strategically important, has produced a run of debut-day surges across the humanoid and embodied-intelligence sector this year, and critics inside China's own financial press have argued the listing process itself, rather than investor conviction, manufactured Unitree's opening pop. A restricted float in the earliest sessions, thin initial liquidity, and retail demand chasing a marquee national robotics name all compound into exactly the kind of first-day spike that a two-week unwind then partially corrects.

That structural reading matters for how buyers should treat the next STAR Market robotics listing, not just this one. Unitree and AgiBot have been racing toward Hong Kong and Shanghai listings on opposite bets about what makes a robot company worth billions, one favoring vertically integrated hardware margins and the other favoring platform breadth and service revenue. Unitree's post-listing round trip is the first hard data point either company's cap table has generated on how China's current listing mechanism actually prices a humanoid robot maker once the debut-day mechanics wear off, and it argues for real skepticism toward whatever multiple the next robotics IPO opens at.

The Fundamentals Underneath the Volatility

Strip out the trading noise and Unitree's underlying business case has not changed in the two weeks since listing. The company remains one of the highest-volume producers of quadruped robots globally and has pushed aggressively into humanoids, competing directly with AgiBot, Fourier Intelligence, and a widening field of Chinese and international rivals on both hardware cost and software capability. DeepSeek's participation in backing the Shanghai listing before the IPO was priced was read at the time as a signal that China's AI sector saw Unitree as infrastructure worth owning equity in, not just a hardware vendor to buy from, and that strategic logic has not reversed because the share price has.

What has changed is the discount buyers now have to apply to any near-term valuation claim tied to the stock. A company whose market capitalization can swing by tens of billions of US dollars in a fortnight without a change in disclosed fundamentals is not a stable reference point for pricing supplier risk, partnership terms, or competitive benchmarking, three things procurement and business-development teams routinely lean on public valuations to do. Buyers evaluating Unitree as a vendor should be pricing the robots and the roadmap, the same inputs that mattered before the IPO, and treating the equity story as a separate and considerably noisier signal.

Reading the Next Two Weeks

The stock's path from here will say more about China's IPO mechanism than about Unitree's robots. If the shares find a floor near current levels and stabilize, that outcome argues the debut-day surge was the anomaly and the post-listing price is closer to a market-clearing valuation informed by real fundamentals. If the slide continues meaningfully past 50 percent from peak, that outcome argues the entire post-IPO price discovery process, not just the first-day pop, has been distorted by the same structural forces critics identified a week ago, and the STAR Market's fast-track listing framework for strategic technology names deserves a harder look before the next humanoid robot company goes through it.

Either reading leaves Unitree's operating business, the robots shipping, the deployments underway, and the competitive position against AgiBot and the rest of the field, doing exactly what it was doing before the ticker started trading. The verdict on the stock price is separate from the verdict on the company, and conflating the two is the mistake this particular two-week chart is best positioned to punish.

How Unitree's Round Trip Compares Abroad

Western humanoid robot makers have taken a different route to public markets, and the contrast sharpens what happened in Shanghai. Agility Robotics went public through a merger with the SPAC Churchill Capital Corp XI at a roughly US$2.5 billion valuation, a structure that priced the company through negotiation with a single sponsor rather than an order book racing to fill on debut morning. That process produced a valuation with far less debut-day theater and, so far, none of the whipsaw Unitree has generated. Figure AI and other well-funded US humanoid makers have stayed private altogether, arguing that public markets are not yet equipped to price a category where most revenue is still years away and the gap between demonstrated capability and deployed fleets remains wide.

Unitree's Shanghai listing tested the opposite bet: that a public order book, even a thin and retail-heavy one, could price a humanoid robot maker more efficiently than private markets have managed. Two weeks of trading have not settled that question so much as illustrated the cost of asking it in real time, with tens of billions of US dollars in market capitalization changing hands as the answer gets worked out one session at a time. Investors in Agility Robotics and the private humanoid makers are watching Unitree's chart for a different reason than sentiment: it is the first live pricing signal the sector has produced for what public markets think a humanoid and quadruped robot maker is actually worth once the introduction period ends.

The Retail Exposure Question

A structural detail worth stating plainly: STAR Market listings draw heavily on mainland retail investors, a base with far less capacity to absorb a 50 percent round trip than the institutional funds that dominate order books on more established exchanges. China's securities regulators have flagged the pattern before, in prior STAR Market debuts that surged and then partially reversed, and each recurrence renews scrutiny of whether the listing rules that enable outsized debut-day pops are serving price discovery or simply transferring wealth from early retail buyers to whoever sold near the top. Unitree's case is now the largest and most closely watched example of that pattern in the robotics sector specifically, and regulators weighing changes to STAR Market listing mechanics will have this trading record as their most current reference.

This analysis synthesizes public trading data, company prospectus disclosures, and reported market commentary as of September 2, 2026.

Image: Unitree Robotics.

This article is provided for general information purposes only and does not constitute investment, financial, or trading advice.